About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker INBX

Latest patent grants
GrantedPatentOwnerTypeSource
Mar 31, 202612590169
5T4 single domain antibodies and therapeutic compositions thereof
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Feb 17, 202612552855
CD33 targeted immunotherapies
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jan 13, 202612522661
CD28 single domain antibodies and multivalent and multispecific const…
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Sep 23, 202512421315
CLL-1 targeted immunotherapies
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jul 22, 202512365728
DLL3 single domain antibodies and therapeutic compositions thereof
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jun 17, 202512331132
Multispecific polypeptide constructs having constrained CD3 binding a…
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jun 17, 202512331126
OX40-binding polypeptides and uses thereof
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
May 13, 202512297271
PD-1 single domain antibodies and therapeutic compositions thereof
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Feb 25, 202512234297
IgE binding proteins and uses thereof
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Feb 18, 202512227584
Multivalent and multispecific OX40-binding fusion proteins
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jan 14, 202512195533
Multispecific polypeptide constructs containing a constrained CD3 bin…
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗
Jan 7, 202512187804
Multivalent and multispecific 41BB-binding proteins
INBX
Inhibrx Biosciences, Inc.
utilityGoogle Patents ↗

12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:28 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances